Non-Linear Pharmacokinetics: Biopharmaceutics (Ashik Sir)
Non-Linear Pharmacokinetics: Biopharmaceutics (Ashik Sir)
Non-Linear Pharmacokinetics: Biopharmaceutics (Ashik Sir)
Non-linear Pharmacokinetics
Question: Derivation of Michaelis-Menten Equation/Non-Liner pharmacokinetic model
Reaction Model:
The enzyme reacts with the substrate by binding to its active site to form the enzyme substrate
complex, ES. That reaction followed by the decomposition of ES to regenerate the free E and the
new product P.
Michaelis-Menten Equation:
ASSUMTION 2: Conditions are such that there is very little accumulation of P (product). So that,
the formation of ES from E + P is negligible. The rate of ES is given by –
ASSUMTION 3: The rate of breakdown of ES very rapidly equal to the rate of formation of ES.
This is the steady state assumption.
Or, K1 [E] [S] = K – 1 [ES] + K2 [ES] {From the equation 1 and equation}
Or, K1 [E] [S] = (K1 + K2) [ES]
Michaelis constant Km is the substrate concentration at which the reaction rate is at half maximum
& is an inverse measure of the substrate’s affinity to the enzyme.
So,
The total amount of enzyme in the system must be the same throughout the experiment but it can
either be free (unbound) E or in complex with substrate, ES. If we term the toral enzyme Et, this
relationship can be written out:
[Et] = [E] + [ES] (4)
From equation 3 and equation 4 we can write –
The maximum rate, which can call Vmax, would be achieved when all of the enzyme molecules
have substrate bound. Under the conditions when [S] is much greater than [E], it is fair to assume
that all E will be in the form ES. Therefore [Et] = [ES]. Thinking again about equation 6, we could
substitute the term Vmax for Vo and [Et] for [ES]. This would give us –
Vmaax = K2 [Et]
From equation 7,
When the drug concentration is low relative to the enzyme concentration, there are abundant
enzymes to catalyze the reaction, and the rate of metabolism is a first-order process.
So, If KM >>> [S] we can write–
KM + [S] = KM
From Michaelis-Menten Equation
Here,
KM = [S]
Or, KM + [S] = [S] + [S] = 2[S]
∴ Vo = Vmax / 2
Saturation of the enzyme usually occurs when the plasma drug concentration is relatively high,
all the enzyme molecules become complexed with drug, and the reaction rate is at a maximum
rate; the rate process then becomes a zero-order process.
So, If KM <<< [S] we can write –
KM + [S] = [S]
From Michaelis-Menten Equation
1) Turnover Number: Number of substrate molecules converted into product by one molecule
of enzyme active site per unit time, when enzyme is fully saturated with substrate.
K2 = kcat = turnover number
MD. ASIF HASAN NILOY
B.Pharm24Batch; 8th Semester Page 3|9
Biopharmaceutics (Ashik Sir)
Non-linear Pharmacokinetics
2) KM: Substrate concentration at which velocity (V0) exactly ½ of Vmax.
K – 1 + K2
KM = Michaelis constant =
K1
It is termed Michaelis – Menten Constant of the drug in the body which reflects the capacity
of the enzyme system, equals to the drug concentration or amount of the drug in the body at
0.5 Vmax and written as
KM also known as substrate concentration when V0 = ½ Vmax
Importance of KM:
[E] [S]
KM =
[ES]
(1) KM determines the affinity of an enzyme for its substrate, lesser the KM more the affinity
and vice versa.
(2) KM value helps in determining the true substrate for the enzyme.
Non-linear Pharmacokinetics: The first order kinetics is usually transformed into mixture of
first order and zero order rate process and the pharmacokinetic parameters are changed with
the size of the administered dose. Pharmacokinetics of these are said to be non-linear/mixed
order/capacity-limited/dose dependent pharmacokinetic.
Dose-dependent pharmacokinetics:
Phenytoin → 300 mg (50% increase) → 450 mg → CSS (10X increase)
Phenytoin undergoes capacity-limited kinetics at therapeutic drug concentrations in the body.
At steady state, the rate of drug metabolism is assumed to be the same as the rate of drug input
(dose/day). Therefore, Equation may be written for drug metabolism in the body similar to the
way drugs are metabolized in vitro.
∴ V0 = Vmax
Linear pharmacokinetic is non-dose dependent pharmacokinetics
(a) What do you mean by the term “Enzyme-Substrate Complex”? Write down its
significance.
Enzyme-Substrate Complex: Substrate binds to enzymes binding site to form a complex
which is termed as enzyme substrate complex.
Significance of it:
[E] [S]
KM =
[ES]
Here,
KM = 50𝛍g/mL
Vmax = 20𝛍g/mL per hour
VD = 20 L/kg = 20,000mL/kg
We know,
IV dose = 10 mg/kg
= 10,000 𝛍g/kg
VD = 20 L/kg
= 20,000mL/kg
Because KM = 50 𝛍g/mL we can write, CP <<< KM and we can say that the reaction rate is first
order.
RM is a 32 years old, 80kg male is being seen in the Neurology clinic. Prior to his last visit
he had been taking 300 mg of phenytoin daily; however, because his seizers were poorly
controlled and because his plasma concentration was only 8mg/K, his dose was
increasing to 360mg daily. Now the complain of minor CNS side effects and his reported
plasma phenytoin concentration is 20mg/L. Renal and hepatic function are normal.
Assume that both of the reported plasma concentrations represent steady state and that the
patient has copied with the prescribed dosing regimen.
a) Calculate RM’s apparent VM and KM.
b) Calculate RM’s a new daily dose of phenytoin that will result in a steady state level of about
15mg/L.